Rare
lephants
Screener
Toggle theme
TherapeuticsMD, Inc.
TXMD
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2022
Total Cash from Operations:
$124.8M
Line Item
Value
% of Total
Working Capital
$115.4M
92.5%
Net Cash Flow
$9.4M
7.5%
Download CSV
